Patent directory · USPTO A61K / A61P
Patents matching “Sarepta Therapeutics, Inc.”
102 pharma patents match "Sarepta Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 102 pharmaceutical patents matching "Sarepta Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11208655
Functionally-modified oligonucleotides and subunits thereof
granted -
US 11097011
Peptide oligonucleotide conjugates
granted -
US 11071749
Oligonucleotide analogues targeting human LMNA
granted -
US 11060089
Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene
granted -
US 11020417
Methods and compounds for treatment of lymphocyte-related diseases and conditions
granted -
US 11015200
Antisense-induced exon exclusion in myostatin
granted -
US 11000600
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 10927378
Compound and method for treating myotonic dystrophy
granted -
US 10905782
Compositions for enhancing transport of molecules into cells
granted -
US 10905709
Modified antisense oligomers for exon inclusion in spinal muscular atrophy
granted -
US 10907154
Exon skipping compositions for treating muscular dystrophy
granted -
US 10888578
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 10849917
Antisense-induced exon exclusion in type VII collagen
granted -
US 10781450
Antisense molecules and methods for treating pathologies
granted -
US 10765760
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 10760078
Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
granted -
US 10758629
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 10675356
Peptide oligonucleotide conjugates
granted -
US 10626396
Antisense composition and method for treating muscle atrophy
granted -
US 10577605
Induced exon inclusion in spinal muscle atrophy
granted -
US 10533174
Splice-region antisense composition and method
granted -
US 10487326
Peptide oligonucleotide conjugates
granted -
US 10479996
Antisense antiviral compound and method for treating ss/RNA viral infection
granted -
US 10364431
Compositions for treating muscular dystrophy
granted